Market Overview The C1 esterase inhibitor subcutaneous market is experiencing growth as hereditary angioedema (HAE) prevalence recognition increases, subcutaneous administration improves accessibility, and self-administered therapy enables patient autonomy for this rare genetic disorder requiring specialized management and prophylactic treatment. The C1 Esterase Inhibitor Subcutaneous Market is...